News | May 03, 2024
Novartis to acquire Mariana Oncology for upfront US$ 1 billion
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
A game changing solution for the pharmaceutical industry
The drug will target specific genetic mutations prevalent in certain types of cancers
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
Automated parallel capillary electrophoresis system simplifies protein analysis
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Subscribe To Our Newsletter & Stay Updated
